Onyx Pharmaceuticals Buys Proteolix, Gaining Blood-Cancer Drug

Onyx Pharmaceuticals Inc. is set to buy Proteolix Inc. for a reported $276 million in order to gain a blood-cancer drug in its experimental stages. The Emeryville, California based company may end up paying $575 million more in future payments for development of the...

36 Cyclists to Pedal 6,800 km across Canada!

One of the world's longest charitable cycling events on behalf of childhood cancer is taking place this summer from June 13 to June 24, 2008. Gordon Drummond, 49 of Peace River, Alberta, is one of the 36 National...

Gene test gives early alert for breast cancer

This story ring me a bell to one patient. She has to pay a lot of money for the medicine. "All women could soon be offered a genetic test which would tell them whether they were likely or unlikely to contract...

Scientists uncover gene signature behind cancer spread

"Washington, May 31 (ANI): U.S. researchers have identified a gene signature responsible for the spread of cancer from one organ to another, a process scientifically known as metastasis. Research collaborators from the Kimmel Cancer Center at Jefferson in Philadelphia and...

2007 Luminous Award Winners Highlight Ovarian Cancer Treatment and the Import...

""The Luminous Award has grown into a truly global event, with more than 70 entries received this year from journalists working in 11 countries," said Garry Nicholson, leader of the Lilly Oncology global brand development team. "This competition is part of Lilly Oncology's...

PPD names VPs for North America and Asia

"Mr. Colvin joins PPD from Eli Lilly and Company where he most recently directed clinical operations and global patient enrollment optimization. During his 14-year career at Lilly, he held a series of leadership positions including chief operations officer for the global...

Clinsys Clinical Research announces key hires

"Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the appointments of Rajagopalan Srinivasan, Ph.D as Vice President, Global Biostatistics and Christopher Gregory, Ph.D as Scientific Affairs-Director. "I am excited to...

Boehringer Ingelheim to Initiate First Phase III Pivotal Study for New Oncolo...

"Study investigator, Dr. James Spicer, Senior Lecturer and Consultant in Medical Oncology at King's College School of Medicine, Guy's Hospital, London, U.K., commented on the findings: "More effective treatments for lung cancer, with fewer side effects, are badly needed....

closeSign in to NowPublic

is reporting from